FRF - Grand Est

Regional Innovation Performance (2019) Strong -

Total population (2019) 5525291

Population per km² (2017) 97

Proportion population older 65 year % 20,34%


Grand Est (Alsace - Champagne-Ardenne - Lorraine) is a region in eastern France. The regions' S3 priorities in Health and Well-being include:  e-health (prevention, autodiagnostic, tele-consultation and remote monitoring);  ICT related aspects of e-health; New drugs (biotech, biomarkers, nanomaterial, genomics, chemistry and biology); Robotics & medical & surgical care (non-invasive mini surgery, micro-robots for the exploration of the body, tele-robotics and re-education, social robots for diagnosis and cognitive & emotional stimulation, robotics software); Tools for assisting diagnosis based on medical imagery (and ultra-sound); Medical implants (passive such as prothesis and active such as pacemakers); Prevention through nutrition.


The region would like to collaborate with: USA, Germany, Belgium, UK

Membership status

Member ICPerMed? no 

Mountain ? Non-mountain

Member Euregha? no 

Adriatic-Ionian MacroRegion? no

InnoStars Region? no 

Northern Sparsely Populated Area (NSPA)? no

PM region according EC? yes 

Baltic Sea MacroRegion? no

S3MedTech region? yes 

Danube MacroRegion? no

S3ClusSport member? no 

Alpine MacroRegion? no

S3P4PM region? no

Regions4PM region? no 

Central Europe? no

MedTech4Europe? no

Council of European BioRegions (CEBR)? no

1M+Genome initiative? country level observer

European Regions Research & Innovation Network (ERRIN)?  yes

Vanguard Initiative? no

ERAPerMed? no

Policy documents

  1. National MaSanté2022

  2. National AIforHumanity 

  3. Régional Stratégie Santé Grand Est 

Topics covered by policies : Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Education, training and skill development; Prediction and prevention; Value based healthcare

- National Reimbursement of e- and mobile health applications 

NACE Personalised Medicine/Personalised Health related to Research and Innovation objectives: C.20 - Chemicals and chemical products; C.21 - Basic   pharmaceutical products and pharmaceutical preparations; J.63 - Information   service activities; Q.86 - Human health activities; M.72 - Scientific   research and development; P - Education

Scientific domain NABS Personalised   Medicine/Personalised Health related to Research and Innovation: NABS07 - Health; NABS133 - R&D related to   Medical Sciences - financed from other sources than GUF

Policy objective Personalised   Medicine/Personalised Health related related to Research and Innovation objectives: D - Digital transformation; E.38 - Advanced   materials; E.39 - Industrial biotechnology; G.46 - Ageing societies; G.49 -   Public health & well-being; H - Service innovation; I.57 - Social innovation   with regard to education, skills & training

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes

Major initiatives

  1. Territoire de Santé de Demain

  2. N'Tech Santé

  3. IHU Strasbourg  Public-private Innovation Center

  4. PRIeSM  e-Health plateform  

  5. Collaborations with Germany, switzerland


Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?


  1. EIT Health/InnoStars/Regional Innovation Scheme (RIS)

  2. Partnership between BioValley France and MEDTEQ Québec 

Self evaluation

General perception of the implementation level of PM in the region - High

Rate of the need for developing and implementing PM in the region - Medium

Rate of the need for increasing support/funding for PM activities in the  region - Very High

Rate of the need for increasing the capacity of PM skills in the region - Medium

Rate of the genomics literacy of the citizens in the region - High

Rate of the need for increasing interregional collaboration in PM - High

Image attribution

By Niko67000 - Own work, CC BY-SA 4.0,

  • LinkedIn
  • Facebook
  • Twitter
  • YouTube

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium